VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.65001
-0.0149 (-2.24%)
Jun 12, 2026, 12:42 PM EDT - Market open
VYNE Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.45 | 0.57 | 0.5 | 0.42 | 0.48 | 0.93 | |
Revenue Growth (YoY) | -24.96% | 13.77% | 18.16% | -11.11% | -48.77% | -95.56% |
Gross Profit | 0.45 | 0.57 | 0.5 | 0.42 | 0.48 | 0.93 |
Selling, General & Admin | 10.89 | 11.08 | 13.19 | 13.38 | 16.39 | 20.3 |
Research & Development | 13.93 | 19.24 | 30.95 | 16.31 | 18.39 | 19.54 |
Other Operating Expenses | 24.82 | 30.32 | 44.14 | 29.68 | 34.77 | 39.84 |
Total Operating Expenses | 49.65 | 60.64 | 88.28 | 59.36 | 69.54 | 79.68 |
Operating Income | -49.19 | -60.07 | -87.78 | -58.94 | -69.07 | -78.75 |
Interest Expense | - | - | - | - | - | 5.61 |
Other Non-Operating Income (Expense) | 2.66 | 3.02 | 3.83 | 1.39 | 0.36 | -0.14 |
Total Non-Operating Income (Expense) | 2.66 | 3.02 | 3.83 | 1.39 | 0.36 | 5.48 |
Pretax Income | -21.71 | -26.73 | -39.8 | -27.87 | -33.93 | -44.66 |
Provision for Income Taxes | 0 | 0 | 0 | - | 0.01 | -0.45 |
Net Income | -21.72 | -26.74 | -39.81 | -27.87 | -33.95 | -44.21 |
Earnings From Discontinued Operations | 0.26 | 0.25 | -0.03 | -0.58 | 10.74 | -29.12 |
Net Income to Common | -21.46 | -26.48 | -39.83 | -28.45 | -23.21 | -73.33 |
Shares Outstanding (Basic) | 33 | 33 | 43 | 10 | 3 | 3 |
Shares Outstanding (Diluted) | 33 | 33 | 43 | 10 | 3 | 3 |
Shares Change (YoY) | -21.73% | -21.76% | 314.57% | 222.44% | 11.44% | 58.75% |
EPS (Basic) | -0.64 | -0.79 | -0.93 | -2.78 | -10.65 | -25.64 |
EPS (Diluted) | -0.64 | -0.79 | -0.93 | -2.78 | -10.65 | -25.64 |
Free Cash Flow | -25.74 | -33.12 | -34.09 | -25.34 | -29.2 | -56.37 |
Free Cash Flow Per Share | -0.77 | -0.99 | -0.80 | -2.47 | -9.17 | -19.72 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -10835.20% | -10538.20% | -17520.00% | -13900.90% | -14479.50% | -8458.97% |
Profit Margin | -4783.70% | -4690.53% | -7945.51% | -6573.58% | -7116.35% | -4748.44% |
FCF Margin | -5670.48% | -5811.23% | -6804.19% | -5976.65% | -6121.59% | -6054.46% |
EBITDA | -49.17 | -60.05 | -87.77 | -58.94 | -69 | -78.64 |
EBITDA Margin | -10830.20% | -10534.20% | -17519.20% | -13900.90% | -14464.40% | -8447.26% |
EBIT | -49.19 | -60.07 | -87.78 | -58.94 | -69.07 | -78.75 |
EBIT Margin | -10835.20% | -10538.20% | -17520.00% | -13900.90% | -14479.50% | -8458.97% |
Effective Tax Rate | -0.02% | -0.01% | -0.01% | 0.00% | -0.04% | 1.00% |